Last 12 months
Inside the activity.
0 purchase rows · 33 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2016 Filed Oct 7, 2016 20:02 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Exercise / conversionPerformance Restricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-064535 · form4.xml · derivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 20,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance restricted stock unit represented a contingent right to receive one ordinary share of Alkermes plc. F2 · derivative.exercise_date: This performance restricted stock unit, which was granted to the reporting person on March 3, 2014, is fully vested in accordance with its terms. F2 · derivative.expiration_date: This performance restricted stock unit, which was granted to the reporting person on March 3, 2014, is fully vested in accordance with its terms. Read SEC document |
| October 05, 2016 Filed Oct 7, 2016 20:02 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Tax withholdingOrdinary Shares | 9,410 | $46.43 | $436,906.30 |
DisclosureSEC source: 0001127602-16-064535 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 608,962 Read SEC document |
| October 05, 2016 Filed Oct 7, 2016 20:02 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Exercise / conversionOrdinary Shares | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-064535 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 618,372 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:25 UTC |
MITCHELL PAUL JDirector
|
Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $18.29 | $0.00 |
DisclosureSEC source: 0001127602-16-064142 · form4.xml · derivative · entry 3 MITCHELL PAUL J · CIK 0001236454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,000 shares Expires 2017-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:25 UTC |
MITCHELL PAUL JDirector
|
SaleOrdinary Shares | 2,000 | $47.42 | $94,840.00 |
DisclosureSEC source: 0001127602-16-064142 · form4.xml · nonDerivative · entry 2 MITCHELL PAUL J · CIK 0001236454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:25 UTC |
MITCHELL PAUL JDirector
|
Exercise / conversionOrdinary Shares | 2,000 | $18.29 | $36,580.00 |
DisclosureSEC source: 0001127602-16-064142 · form4.xml · nonDerivative · entry 1 MITCHELL PAUL J · CIK 0001236454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 22, 2016 Filed Sep 22, 2016 21:01 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,834 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-16-063082 · form4.xml · derivative · entry 6 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Underlying: Ordinary Shares · 3,834 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| September 22, 2016 Filed Sep 22, 2016 21:01 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
SaleOrdinary Shares | 3,834 | $50.84 | $194,926.31 |
DisclosureSEC source: 0001127602-16-063082 · form4.xml · nonDerivative · entry 4 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,311 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.80 to $51.00 Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 22, 2016 Filed Sep 22, 2016 21:01 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 3,834 | $18.11 | $69,414.57 |
DisclosureSEC source: 0001127602-16-063082 · form4.xml · nonDerivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 21, 2016 Filed Sep 22, 2016 21:01 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,166 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-16-063082 · form4.xml · derivative · entry 5 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,834 Underlying: Ordinary Shares · 1,166 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| September 21, 2016 Filed Sep 22, 2016 21:01 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
SaleOrdinary Shares | 1,166 | $50.81 | $59,242.24 |
DisclosureSEC source: 0001127602-16-063082 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,311 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.80 to $50.835. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 21, 2016 Filed Sep 22, 2016 21:01 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 1,166 | $18.11 | $21,110.43 |
DisclosureSEC source: 0001127602-16-063082 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 16, 2016 Filed Sep 19, 2016 21:21 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-16-062828 · form4.xml · derivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,000 Underlying: Ordinary Shares · 5,000 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| September 16, 2016 Filed Sep 19, 2016 21:21 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
SaleOrdinary Shares | 5,000 | $48.87 | $244,330.50 |
DisclosureSEC source: 0001127602-16-062828 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,311 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.80 to $49.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 16, 2016 Filed Sep 19, 2016 21:21 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 5,000 | $18.11 | $90,525.00 |
DisclosureSEC source: 0001127602-16-062828 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 14, 2016 Filed Sep 15, 2016 21:03 UTC |
snyderman nancy lynn MDDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 16,200 | $0.00 Strike: $47.65 | $0.00 |
DisclosureSEC source: 0001127602-16-062563 · form4.xml · derivative · entry 2 snyderman nancy lynn MD · CIK 0001675198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,200 Underlying: Ordinary Shares · 16,200 shares Expires 2026-09-14 F2 · derivative.exercise_date: This option becomes exercisable in full on 9/14/17. Read SEC document |
| September 14, 2016 Filed Sep 15, 2016 21:03 UTC |
snyderman nancy lynn MDDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 27,400 | $0.00 Strike: $47.65 | $0.00 |
DisclosureSEC source: 0001127602-16-062563 · form4.xml · derivative · entry 1 snyderman nancy lynn MD · CIK 0001675198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,400 Underlying: Ordinary Shares · 27,400 shares Expires 2026-09-14 F1 · derivative.exercise_date: This option vests in 3 equal annual installments commencing on 9/14/17. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 21:31 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-16-062129 · form4.xml · derivative · entry 4 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: Ordinary Shares · 10,000 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 21:31 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
SaleOrdinary Shares | 2,500 | $46.31 | $115,782.00 |
DisclosureSEC source: 0001127602-16-062129 · form4.xml · nonDerivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,311 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.26 to $46.48. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 21:31 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
SaleOrdinary Shares | 7,500 | $45.93 | $344,453.25 |
DisclosureSEC source: 0001127602-16-062129 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,811 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.265 to $46.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 21:31 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 10,000 | $18.11 | $181,050.00 |
DisclosureSEC source: 0001127602-16-062129 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 21:27 UTC |
Brown Iain MichaelSVP Finance & CAO, Alks Inc.
|
SaleOrdinary Shares | 3,469 | $46.36 | $160,817.29 |
DisclosureSEC source: 0001127602-16-062128 · form4.xml · nonDerivative · entry 2 Brown Iain Michael · CIK 0001643456 · SVP Finance & CAO, Alks Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,227 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.28 to $46.45. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 21:27 UTC |
Brown Iain MichaelSVP Finance & CAO, Alks Inc.
|
SaleOrdinary Shares | 26,507 | $45.87 | $1,215,809.82 |
DisclosureSEC source: 0001127602-16-062128 · form4.xml · nonDerivative · entry 1 Brown Iain Michael · CIK 0001643456 · SVP Finance & CAO, Alks Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,696 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.28 to $46.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 21:16 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,382 | $0.00 Strike: $14.38 | $0.00 |
DisclosureSEC source: 0001127602-16-062123 · form4.xml · derivative · entry 3 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,618 Underlying: Ordinary Shares · 2,382 shares Expires 2016-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 21:16 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
SaleOrdinary Shares | 2,382 | $45.92 | $109,378.11 |
DisclosureSEC source: 0001127602-16-062123 · form4.xml · nonDerivative · entry 2 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,434 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.37 to $46.32. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 21:16 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 2,382 | $14.38 | $34,253.16 |
DisclosureSEC source: 0001127602-16-062123 · form4.xml · nonDerivative · entry 1 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 21:13 UTC |
MITCHELL PAUL JDirector
|
Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $18.29 | $0.00 |
DisclosureSEC source: 0001127602-16-062122 · form4.xml · derivative · entry 4 MITCHELL PAUL J · CIK 0001236454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Ordinary Shares · 2,000 shares Expires 2017-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 21:13 UTC |
MITCHELL PAUL JDirector
|
SaleOrdinary Shares | 400 | $46.28 | $18,510.00 |
DisclosureSEC source: 0001127602-16-062122 · form4.xml · nonDerivative · entry 3 MITCHELL PAUL J · CIK 0001236454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.26 to $46.29. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 21:13 UTC |
MITCHELL PAUL JDirector
|
SaleOrdinary Shares | 1,600 | $45.83 | $73,324.48 |
DisclosureSEC source: 0001127602-16-062122 · form4.xml · nonDerivative · entry 2 MITCHELL PAUL J · CIK 0001236454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,400 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.2650 to $46.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 21:13 UTC |
MITCHELL PAUL JDirector
|
Exercise / conversionOrdinary Shares | 2,000 | $18.29 | $36,580.00 |
DisclosureSEC source: 0001127602-16-062122 · form4.xml · nonDerivative · entry 1 MITCHELL PAUL J · CIK 0001236454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| August 04, 2016 Filed Oct 7, 2016 01:04 UTC |
FRATES JAMES MSVP, Alks Inc; CFO ALKS
|
GiftOrdinary Shares | 4,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-064471 · form4.xml · nonDerivative · entry 1 FRATES JAMES M · CIK 0001235598 · SVP, Alks Inc; CFO ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,924 F1 · balance_after: Includes 9,760 shares received on June 2, 2016 pursuant to an annuity payment from the James M. Frates Grantor Retained Annuity Trust dated March 14, 2014 (the "2014 GRAT"), which was exempt from reporting obligations by virtue of Rule 16a-13 promulgated under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Includes 24,861 shares received on September 9, 2016 pursuant to an annuity payment from the James M. Frates Grantor Retained Annuity Trust dated May 29, 2015 (the "2015 GRAT"), which was exempt from reporting obligations by virtue of Rule 16a-13 promulgated under the Securities Exchange Act of 1934, as amended. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.